| Myeloid-derived suppressor cells coming of age MPDG Filippo Veglia Nature Immunology, 2018 | 1747 | 2018 |
| LAG-3 expression defines a subset of CD4+ CD25highFoxp3+ regulatory T cells that are expanded at tumor sites C Camisaschi, C Casati, F Rini, M Perego, A De Filippo, F Triebel, ... The Journal of Immunology 184 (11), 6545-6551, 2010 | 410 | 2010 |
| Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation DIGJZ Yu-Mei He, Xing Li, Michela Perego, Yulia Nefedova, Andrew V Kossenkov ... nature medicine, 2018 | 194 | 2018 |
| Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils M Perego, VA Tyurin, YY Tyurina, J Yellets, T Nacarelli, C Lin, Y Nefedova, ... Science translational medicine 12 (572), eabb5817, 2020 | 169 | 2020 |
| Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy R Somasundaram, T Connelly, R Choi, H Choi, A Samarkina, L Li, ... Nature communications 12 (1), 346, 2021 | 156 | 2021 |
| A comprehensive patient-derived xenograft collection representing the heterogeneity of melanoma C Krepler, K Sproesser, P Brafford, M Beqiri, B Garman, M Xiao, ... Cell reports 21 (7), 1953-1967, 2017 | 142 | 2017 |
| Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer T Kwak, F Wang, H Deng, T Condamine, V Kumar, M Perego, ... Cell reports 33 (13), 2020 | 140 | 2020 |
| Tumor-associated B-cells induce tumor heterogeneity and therapy resistance Nature Communications doi: 10.1038/s41467-017-00452-4. 8 (1), 607, 2017 | 138* | 2017 |
| Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells M Perego, M Tortoreto, G Tragni, L Mariani, P Deho, A Carbone, ... Journal of investigative dermatology 130 (7), 1877-1886, 2010 | 101 | 2010 |
| W nt5 A promotes an adaptive, senescent‐like stress response, while continuing to drive invasion in melanoma cells MR Webster, M Xu, KA Kinzler, A Kaur, J Appleton, MP O'Connell, ... Pigment cell & melanoma research 28 (2), 184-195, 2015 | 99 | 2015 |
| heterogeneity in melanoma B Shannan*, M Perego*, R Somasundaram, M Herlyn melanoma 167, chapter 1, 2015 | 98 | 2015 |
| A slow-cycling subpopulation of melanoma cells with highly invasive properties M Perego, M Maurer, JX Wang, S Shaffer, AC Müller, K Parapatics, L Li, ... Oncogene 37 (3), 302-312, 2018 | 86 | 2018 |
| Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice Y Liu, M Perego, Q Xiao, Y He, S Fu, J He, W Liu, X Li, Y Tang, X Li, ... The Journal of clinical investigation 129 (10), 4261-4275, 2019 | 80 | 2019 |
| Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target K Rasanen, S Sriswasdi, A Valiga, HY Tang, G Zhang, M Perego, ... Molecular & Cellular Proteomics 12 (12), 3778-3792, 2013 | 45 | 2013 |
| Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability JC Ghosh, M Perego, E Agarwal, I Bertolini, Y Wang, AR Goldman, ... Proceedings of the National Academy of Sciences 119 (8), e2115624119, 2022 | 27 | 2022 |
| PIM kinases as therapeutic targets against advanced melanoma B Shannan, A Watters, Q Chen, S Mollin, M Dörr, E Meggers, X Xu, ... Oncotarget 7 (34), 54897, 2016 | 25 | 2016 |
| Immunomodulatory factors control the fate of melanoma tumor initiating cells A Tuccitto, M Tazzari, V Beretta, F Rini, C Miranda, A Greco, M Santinami, ... Stem Cells 34 (10), 2449-2460, 2016 | 24 | 2016 |
| Enhancing the evaluation of PI 3K inhibitors through 3D melanoma models B Shannan, Q Chen, A Watters, M Perego, C Krepler, R Thombre, L Li, ... Pigment cell & melanoma research 29 (3), 317-328, 2016 | 15 | 2016 |
| Mitochondrial fitness and cancer risk AV Kossenkov, A Milcarek, F Notta, GH Jang, JM Wilson, S Gallinger, ... PLoS One 17 (10), e0273520, 2022 | 12 | 2022 |
| NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment I Bertolini, M Perego, JC Ghosh, AV Kossenkov, DC Altieri Oncogene 41 (17), 2520-2525, 2022 | 11 | 2022 |
Antonino CarboneChairman Department of Pathology, IRCCS - C.R.O. Centro di Riferimento Oncologico di AvianoOverená e-mailová adresa na: cro.it